Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 234

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration Policy

Merkatz, Ruth B., Temple, Robert, Sobel, Solomon, Feiden, Karyn, Kessler, David A.·1993·New England Journal of Medicine

Abstract

The Food and Drug Administration (FDA) is taking two important steps to ensure that new drugs are properly evaluated in women. First, it is providing formal guidance to drug developers to emphasize its expectations that women will be appropriately represented in clinical studies and that new drug applications will include analyses capable of identifying potential differences in drug actions or efficacy between the sexes. Second, the agency is altering a 16-year-old policy that has excluded most women with "childbearing potential" from the earliest phases of clinical trials. Attention to sex differences is part of a larger effort by the FDA to ensure that the safety and efficacy of drugs are adequately studied in the full range of patients who will receive therapy and that information is obtained that will allow physicians to individualize therapy. These actions are also being taken in response to questions about whether this country's drug-development process produces adequate information about the effects of drugs in women, as well as more general issues concerning women's health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199307223290429

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Metadata

Authors
Merkatz, R. B., Temple, R., Sobel, S., Feiden, K., & Kessler, D. A.
Venue
New England Journal of Medicine
Published
1993-07-22
Volume
329
Issue
4
Pages
292-296
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2328661576
Cited by
234
References
2
FWCI
16.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration Policy. https://app.cochat.ai/papers/10.1056/nejm199307223290429
The paper
Merkatz, R. B., Temple, R., Sobel, S., Feiden, K., & Kessler, D. A. (1993). Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration Policy. New England Journal of Medicine. https://doi.org/10.1056/nejm199307223290429

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.